The DOI matches its Crossref record; 52 of the 52 references it cites were found in a registry or an index.
Liposome encapsulation of curcumin and resveratrol in combination reduces prostate cancer incidence in PTEN knockout mice
Open accessAbstract
Increasing interest in the use of phytochemicals to reduce prostate cancer led us to investigate 2 potential agents, curcumin and resveratrol as preventive agents. However, there is concern about the bioavailability of these agents pertinent to the poor absorption and thereby limiting its clinical use. With the view to improve their bioavailability, we used the liposome encapsulated curcumin, and resveratrol individually and in combination in male B6C3F1/J mice. Further, we examined the chemopreventive effect of liposome encapsulated curcumin and resveratrol in combination in prostate‐specific PTEN knockout mice. In vitro assays using PTEN‐CaP8 cancer cells were performed to investigate the combined effects curcumin with resveratrol on (i) cell growth, apoptosis and cell cycle (ii) impact on activated p‐Akt, cyclin D1, m‐TOR and androgen receptor (AR) proteins involved in tumor progression. HPLC analysis of serum and prostate tissues showed a significant increase in curcumin level when liposome encapsulated curcumin coadministered with liposomal resveratrol (p < 0.001). Combination of liposomal forms of curcumin and resveratrol significantly decreased prostatic adenocarcinoma in vivo (p < 0.001). In vitro studies revealed that curcumin plus resveratrol effectively inhibit cell growth and induced apoptosis. Molecular targets activated due to the loss of phosphatase and tensin homolog (PTEN) including p‐Akt, cyclin D1, mammalian target of rapamycin and AR were downregulated by these agents in combination. Findings from this study for the first time provide evidence on phytochemicals in combination to enhance chemopreventive efficacy in prostate cancer. These findings clearly suggest that phytochemicals in combination may reduce prostate cancer incidence due to the loss of the tumor suppressor gene PTEN. © 2009 UICC
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Jemal, A., Siegel, R., Ward, E., Hao, Y., Xu, J., Murray, T., & Thun, M. J. (2008) · CA: A Cancer Journal for Clinicians · doi:10.3322/ca.2007.0010 · Cited by 10,188
Simultaneous Statistical Inference
Miller, R. G. (1981) · Springer Series in Statistics · doi:10.1007/978-1-4613-8122-8 · Cited by 5,604
Cancer chemopreventive activity of resveratrol, a natural product derived from grapes
Jang, M., Cai, L., Udeani, G. O., Slowing, K. V., Thomas, C. F., Beecher, C. W. W., Fong, H. H. S., Farnsworth, N. R., Kinghorn, A. D., Mehta, R. G., et al. (1997) · Science · doi:10.1126/science.275.5297.218 · Cited by 4,935 · cited 1×
“Similarly, resveratrol, a phytoalexin found in grapes and red wines has been identified as an antioxidant and antimutagen that induces Phase II drug-metabolizing enzymes, mediates anti-inflammatory effects, reduces cyclooxygenase and inhibits hydroperoxidase functions, such as antipromotion activity.(15) The chemoprev…”
BackgroundResveratrol improves health and survival of mice on a high-calorie diet
Baur, J. A., Pearson, K. J., Price, N. L., Jamieson, H. A., Lerin, C., Kalra, A., Prabhu, V. V., Allard, J. S., Lopez-Lluch, G., Lewis, K., et al. (2006) · Nature · doi:10.1038/nature05354 · Cited by 4,290
Therapeutic potential of resveratrol: the in vivo evidence
Baur, J. A., & Sinclair, D. A. (2006) · Nature Reviews Drug Discovery · doi:10.1038/nrd2060 · Cited by 3,958
HIGH ABSORPTION BUT VERY LOW BIOAVAILABILITY OF ORAL RESVERATROL IN HUMANS
Walle, T., Hsieh, F., DeLegge, M. H., Oatis, J. E., & Walle, U. K. (2004) · Drug Metabolism and Disposition · doi:10.1124/dmd.104.000885 · Cited by 1,880
Molecular targets of dietary agents for prevention and therapy of cancer
Aggarwal, B. B., & Shishodia, S. (2006) · Biochemical Pharmacology · doi:10.1016/j.bcp.2006.02.009 · Cited by 1,754
Papahadjopoulos, D., Allen, T. M., Gabizon, A., Mayhew, E., Matthay, K., Huang, S. K., Lee, K. D., Woodle, M. C., Lasic, D. D., & Redemann, C. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.24.11460 · Cited by 1,620
Ammon, H., & Wahl, M. (1991) · Planta Medica · doi:10.1055/s-2006-960004 · Cited by 1,347
Wang, S., Gao, J., Lei, Q., Rozengurt, N., Pritchard, C., Jiao, J., Thomas, G. V., Li, G., Roy-Burman, P., Nelson, P. S., et al. (2003) · Cancer Cell · doi:10.1016/s1535-6108(03)00215-0 · Cited by 1,109
Biological activities of Curcuma longa L.
Araújo, C., & Leon, L. (2001) · Memórias do Instituto Oswaldo Cruz · doi:10.1590/s0074-02762001000500026 · Cited by 766
Speakman, J. R., Talbot, D. A., Selman, C., Snart, S., McLaren, J. S., Redman, P., Krol, E., Jackson, D. M., Johnson, M. S., & Brand, M. D. (2004) · Aging Cell · doi:10.1111/j.1474-9728.2004.00097.x · Cited by 761
Li, L., Braiteh, F. S., & Kurzrock, R. (2005) · Cancer · doi:10.1002/cncr.21300 · Cited by 644
McMenamin, M. E., Soung, P., Perera, S., Kaplan, I. D., Loda, M. F., & Sellers, W. R. (1999) · PubMed · Cited by 640
Kawamori, T., Lubet, R., Steele, V. E., Kelloff, G. J., Kaskey, R. B., Rao, C. V., & Reddy, B. S. (1999) · PubMed · Cited by 589
Plant-derived anticancer agents
Pezzuto, J. M. (1997) · Biochemical Pharmacology · doi:10.1016/s0006-2952(96)00654-5 · Cited by 565
Metabolism of the cancer chemopreventive agent curcumin in human and rat intestine.
Ireson, C. R., Jones, D. J. L., Orr, S., Coughtrie, M. W. H., Boocock, D. J., Williams, M. L., Farmer, P. B., Steward, W. P., & Gescher, A. J. (2002) · PubMed · Cited by 561
Curcumin downregulates cell survival mechanisms in human prostate cancer cell lines
Mukhopadhyay, A., Bueso-Ramos, C., Chatterjee, D., Pantazis, P., & Aggarwal, B. B. (2001) · Oncogene · doi:10.1038/sj.onc.1204997 · Cited by 441
Cancer Chemopreventive Activity of Resveratrol
BHAT, K. P. L., & PEZZUTO, J. M. (2002) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2002.tb02918.x · Cited by 398
Wu, X., Wu, J., Huang, J., Powell, W. C., Zhang, J., Matusik, R. J., Sangiorgi, F. O., Maxson, R. E., Sucov, H. M., & Roy-Burman, P. (2001) · Mechanisms of Development · doi:10.1016/s0925-4773(00)00551-7 · Cited by 390
Inhibition of cancer growth by resveratrol is related to its low bioavailability
Asensi, M., Medina, I., Ortega, A., Carretero, J., Baño, M. C., Obrador, E., & Estrela, J. M. (2002) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(02)00911-5 · Cited by 388
Cre/loxP‐mediated inactivation of the murine Pten tumor suppressor gene
Lesche, R., Groszer, M., Gao, J., Wang, Y., Messing, A., Sun, H., Liu, X., & Wu, H. (2002) · genesis · doi:10.1002/gene.10036 · Cited by 386
Dorai, T., Cao, Y., Dorai, B., Buttyan, R., & Katz, A. E. (2001) · The Prostate · doi:10.1002/pros.1074 · Cited by 338
Li, L., Ahmed, B., Mehta, K., & Kurzrock, R. (2007) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-06-0556 · Cited by 332
Belguendouz, L., Fremont, L., & Linard, A. (1997) · Biochemical Pharmacology · doi:10.1016/s0006-2952(96)00820-9 · Cited by 299
Modulation of prostate cancer genetic risk by omega-3 and omega-6 fatty acids
Berquin, I. M., Min, Y., Wu, R., Wu, J., Perry, D., Cline, J. M., Thomas, M. J., Thornburg, T., Kulik, G., Smith, A., et al. (2007) · Journal of Clinical Investigation · doi:10.1172/jci31494 · Cited by 282
Meng, X., Maliakal, P., Lu, H., Lee, M.-J., & Yang, C. S. (2004) · Journal of Agricultural and Food Chemistry · doi:10.1021/jf030582e · Cited by 281
Ma, Z., Shayeganpour, A., Brocks, D. R., Lavasanifar, A., & Samuel, J. (2007) · Biomedical Chromatography · doi:10.1002/bmc.795 · Cited by 203
Recent studies on the biofunctions and biotransformations of curcumin
Lin, J., Pan, M., & Lin‐Shiau, S. (2000) · BioFactors · doi:10.1002/biof.5520130125 · Cited by 197
Anti-metastatic activity of curcumin and catechin
Menon, L. G., Kuttan, R., & Kuttan, G. (1999) · Cancer Letters · doi:10.1016/s0304-3835(99)00098-1 · Cited by 181
Steele, V. E. (2000) · Carcinogenesis · doi:10.1093/carcin/21.1.63 · Cited by 179
Jannin, B., Menzel, M., Berlot, J.-P., Delmas, D., Lançon, A., & Latruffe, N. (2004) · Biochemical Pharmacology · doi:10.1016/j.bcp.2004.04.028 · Cited by 175
Jiao, J., Wang, S., Qiao, R., Vivanco, I., Watson, P. A., Sawyers, C. L., & Wu, H. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-4202 · Cited by 172
Signal transduction events elicited by cancer prevention compounds
Kong, A.-N. T., Yu, R., Hebbar, V., Chen, C., Owuor, E., Hu, R., Ee, R., & Mandlekar, S. (2001) · Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis · doi:10.1016/s0027-5107(01)00182-8 · Cited by 169
Narayanan, B. A., Narayanan, N. K., Re, G. G., & Nixon, D. W. (2003) · International Journal of Cancer · doi:10.1002/ijc.10932 · Cited by 165
Self-citationResveratrol suppresses prostate cancer progression in transgenic mice
Harper, C. E., Patel, B. B., Wang, J., Arabshahi, A., Eltoum, I. A., & Lamartiniere, C. A. (2007) · Carcinogenesis · doi:10.1093/carcin/bgm144 · Cited by 160
Deeb, D., Jiang, H., Gao, X., Hafner, M. S., Wong, H. K., Divine, G., Chapman, R., Dulchavsky, S. A., & Gautam, S. C. (2004) · PubMed · Cited by 141
Shankar, S., Chen, Q., Sarva, K., Siddiqui, I. A., & Srivastava, R. K. (2007) · Journal of Molecular Signaling · doi:10.1186/1750-2187-2-10 · Cited by 138
Deeb, D., Jiang, H., Gao, X., Hafner, M. S., Wong, H., Divine, G., Chapman, R., Dulchavsky, S. A., & Gautam, S. C. (2004) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.803.3.7 · Cited by 131
Wang, T.-C., Hudson, T., Wang, T.-C., Remsberg, C. M., Davies, N. M., Takahashi, Y., Kim, Y. S., Seifried, H. E., Vinyard, B. T., Perkins, S. N., et al. (2008) · Carcinogenesis · doi:10.1093/carcin/bgn131 · Cited by 119
Dietary factors in cancer of the lower urinary tract
Nomura, A. M. Y., Kolonel, L. N., Hankin, J. H., & YOSHIZAWA, C. N. (1991) · International Journal of Cancer · doi:10.1002/ijc.2910480208 · Cited by 115
Cheung, K. L., Khor, T. O., & Kong, A. T. (2008) · Pharmaceutical Research · doi:10.1007/s11095-008-9734-9 · Cited by 106
Oral Grape Seed Extract Inhibits Prostate Tumor Growth and Progression in TRAMP Mice
Raina, K., Singh, R. P., Agarwal, R., & Agarwal, C. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-0295 · Cited by 100
Hahm, E., Arlotti, J. A., Marynowski, S. W., & Singh, S. V. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-1926 · Cited by 98
Phytochemicals as potential chemopreventive and chemotherapeutic agents in hepatocarcinogenesis
Mann, C. D., Neal, C. P., Garcea, G., Manson, M. M., Dennison, A. R., & Berry, D. P. (2008) · European Journal of Cancer Prevention · doi:10.1097/cej.0b013e3282f0c090 · Cited by 94
Narayanan, B. A. (2006) · Current Cancer Drug Targets · doi:10.2174/156800906779010218 · Cited by 90
Self-citationGill, C., Walsh, S. E., Morrissey, C. M., Fitzpatrick, J. M., & Watson, R. W. G. (2007) · The Prostate · doi:10.1002/pros.20653 · Cited by 87
Narayanan, B. A., Condon, M. S., Bosland, M. C., Narayanan, N. K., & Reddy, B. S. (2003) · PubMed · Cited by 72
Self-citationConsumption of vegetables and fruits and urothelial cancer incidence: a prospective study.
Zeegers, M. P., Goldbohm, R. A., & van den Brandt, P. A. (2001) · PubMed · Cited by 69
Clinical development plan: Curcumin
(1996) · Journal of Cellular Biochemistry · doi:10.1002/jcb.240630706 · Cited by 62
Narayanan, B. A., Narayanan, N. K., Davis, L., & Nargi, D. (2006) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-05-0520 · Cited by 53
Self-citationOncogenicity evaluation of resveratrol in p53(±) (p53 knockout) mice
Horn, T. L., Cwik, M., Morrissey, R. L., Kapetanović, I. M., Crowell, J. A., Booth, T. D., & McCormick, D. L. (2006) · Food and Chemical Toxicology · doi:10.1016/j.fct.2006.07.015 · Cited by 38
Cited by
Sun, D., Zhuang, X., Xiang, X., Liu, Y., Zhang, S., Liu, C., Barnes, S., Grizzle, W., Miller, D., & Zhang, H.-G. (2010) · Molecular Therapy · doi:10.1038/mt.2010.105 · Cited by 1,572
Discovery of curcumin, a component of golden spice, and its miraculous biological activities
Gupta, S. C., Patchva, S., Koh, W., & Aggarwal, B. B. (2012) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/j.1440-1681.2011.05648.x · Cited by 856
Curcumin nanoformulations: a future nanomedicine for cancer
Yallapu, M. M., Jaggi, M., & Chauhan, S. C. (2012) · Drug Discovery Today · doi:10.1016/j.drudis.2011.09.009 · Cited by 751
Curcumin: An Anti-Inflammatory Molecule from a Curry Spice on the Path to Cancer Treatment
Basnet, P., & Skalko-Basnet, N. (2011) · Molecules · doi:10.3390/molecules16064567 · Cited by 733
Administration of resveratrol: What formulation solutions to bioavailability limitations?
Amri, A., Chaumeil, J. C., Sfar, S., & Charrueau, C. (2012) · Journal of Controlled Release · doi:10.1016/j.jconrel.2011.09.083 · Cited by 620
Metadata
- Authors
- Narayanan, N. K., Nargi, D., Randolph, C., & Narayanan, B. A.
- Venue
- International Journal of Cancer
- Publisher
- Wiley
- Published
- 2009-03-26
- Volume
- 125
- Issue
- 1
- Pages
- 1-8
- ISSN
- 0020-7136 (ISSN-L)
- 1097-0215
- OpenAlex
- W2033203721
- Cited by
- 353
- References
- 52
- FWCI
- 11.98
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.